Chronic prostatitis
Conditions
Interventions
Control group:Tamoxine hydrochloride sustained release capsule
Sponsors
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-50 years old; 2. Those who meet the diagnostic criteria of CP/CPPS Western medicine; 3. Comply with the criteria of TCM syndrome differentiation of damp heat syndrome; 4. The course of disease is more than 3 months; 5. At least 2 weeks after stopping treatment at the time of treatment.
Exclusion criteria
Exclusion criteria: 1. Allergic constitution or allergic to the drug; 2. Bacterial culture or mycoplasma, chlamydia and other pathogenic microorganisms positive; 3. With prostate hyperplasia, prostate cancer patients; 4. Combined with other genitourinary diseases and other diseases; 5. Combined Severe cardiovascular and cerebrovascular, liver and kidney dysfunction and hematopoietic system diseases; 6. Unable to cooperate, such as mental patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI; | — |
Countries
China
Contacts
Public ContactGao Qinghe
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed